SENS Foundation and the Rise of Rejuvenation Biotechnology

Mike Kope’s closing speech at SENS5: SENS Foundation’s progress and future goals.

SENS is an acronym for “Strategies for Engineered Negligible Senescence”. It is best defined as an integrated set of medical techniques designed to restore youthful molecular and cellular structure to aged tissues and organs. Essentially, this involves the application of regenerative medicine to the problem of age-related ill-health. However, regenerative medicine is usually thought of as encompassing a few specific technologies such as stem cell therapy and tissue engineering, whereas SENS incorporates a variety of other techniques to remove or obviate the accumulating damage of aging. This broadly defined regenerative medicine – which includes the repair of living cells and extracellular material in situ – applied to damage of aging, is what we refer to as rejuvenation biotechnologies.

Currently, SENS comprises seven major types of therapy addressing seven major categories of aging damage

The SENS Foundation Youtube channel is here

SENS 5 conference abstracts are here

If you liked this article, please give it a quick review on ycombinator or StumbleUpon. Thanks